Incidence of blast phase in myelofibrosis according to anemia severity

Myelofibrosis (MF) is a clonal malignancy frequently characterized by anemia and in 10%–20% of cases it can evolve into blast phase (BP). Anemia in MF is associated with reduced survival and ‐in primary MF‐ also with an increased probability of BP. Conventional treatments for anemia have limited eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora, Barbara, Maffioli, Margherita, Rumi, Elisa, Guglielmelli, Paola, Caramella, Marianna, Kuykendall, Andrew, Palandri, Francesca, Iurlo, Alessandra, De Stefano, Valerio, Kiladjian, Jean‐Jacques, Elli, Elena M., Polverelli, Nicola, Gotlib, Jason, Albano, Francesco, Silver, Richard T., Benevolo, Giulia, Ross, David M., Devos, Timothy, Borsani, Oscar, Barbui, Tiziano, Porta, Matteo G. Della, Bertù, Lorenza, Komrokji, Rami, Vannucchi, Alessandro M., Passamonti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435699/
https://www.ncbi.nlm.nih.gov/pubmed/37601878
http://dx.doi.org/10.1002/jha2.745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435699/
https://www.ncbi.nlm.nih.gov/pubmed/37601878
http://dx.doi.org/10.1002/jha2.745

Ejemplares similares